Cutaneous metabolism in transdermal drug delivery

Current Drug Metabolism

Volumn 10, Issue 3, 2009, Pages 227-235

  Zhang, Qian ^a,b   Grice, Jeffrey E ^b   Wang, Guangji ^a   Roberts, Michael S ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cutaneous metabolism; Enzymes; Prodrug; Transdermal drug delivery; Transporters

Indexed keywords

ALCOHOL; AMINOLEVULINIC ACID; CARRIER PROTEINS AND BINDING PROTEINS; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2S1; DRUG METABOLIZING ENZYME; FLUOROURACIL; MONOCARBOXYLATE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN; NALTREXONE; OLIGOPEPTIDE TRANSPORTER; ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER; PENETRATION ENHANCING AGENT; PRODRUG; PROSTAGLANDIN TRANSPORTER; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ACNE; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPORT; CELL VIABILITY; CULTURE TECHNIQUE; DRUG METABOLISM; ELECTROPORATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; KERATINOCYTE; LIPOPHILICITY; MAMMAL; MAMMALIAN SKIN; MULTIPHOTON MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKIN ABSORPTION; SKIN CELL; SKIN METABOLISM; SKIN STRUCTURE; TISSUE METABOLISM; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CARRIER PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; PRODRUGS; SKIN; SKIN ABSORPTION; SKIN DISEASES; VEHICLES;

EID: 65549108690     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009787846350     Document Type: Review

References (113)

1. Pannatier, A.; Jenner, P.; Testa, B.; Etter, J.C. The skin as a drug-metabolizing organ. Drug Metab. Rev., 1978, 8(2), 319-343.
2. Hotchkiss, S.A.M. In Dermal Absorption and Toxicity Assessment; Roberts, M.S.; Walters, K.A., Eds.; Marcel Dekker: New York, 1998, Vol. 91, pp. 43-101.
3. Sinha, V.R.; Kaur, M.P. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm., 2000, 26(11), 1131-1140.
4. Kao, J.; Carver, M.P. Cutaneous metabolism of xenobiotics. Drug Metab Rev., 1990, 22(4), 363-410.
5. Wilkinson, S.C.; Williams, F.M. In Dermal Absorption and Toxicity Assessment, 2nd ed.; Roberts, M.S.; Walters, K.A., Eds.; Informa Healthcare USA: New York, 2007; Vol. 177, pp. 89-115.
6. Merk, H.F.; Mukhtar, H.; Kaufmann, I.; Das, M.; Bickers, D.R. Human hair follicle benzo[a]pyrene and benzo[a]pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo. J. Invest. Dermatol., 1987, 88(1), 71-76.
7. Katiyar, S.K.; Matsui, M.S.; Mukhtar, H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol., 2000, 114(2), 328-333.
8. Janmohamed, A.; Dolphin, C.T.; Phillips, I.R.; Shephard, E.A. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem. Pharmacol., 2001, 62(6), 777-786.
9. Baron, J.M.; Wiederholt, T.; Heise, R.; Merk, H.F.; Bickers, D.R. Expression and function of cytochrome p450-dependent enzymes in human skin cells. Curr. Med. Chem., 2008, 15(22), 2258-2264.
10. Lockley, D.J.; Howes, D.; Williams, F.M. Cutaneous metabolism of glycol ethers. Arch. Toxicol., 2005, 79(3), 160-168.
11. Oesch, F.; Fabian, E.; Oesch-Bartlomowicz, B.; Werner, C.; Landsiedel, R. Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab. Rev., 2007, 39(4), 659-698.
12. Hikima, T.; Maibach, H.I. Gender differences of enzymatic activity and distribution of 17beta-hydroxysteroid dehydrogenase in human skin in vitro. Skin Pharmacol. Physiol., 2007, 20(4), 168-174.
13. Wermuth, C.G.; Ganellin, C.R.; Lindberg, P.; Mitscher, L.A. Grossary of terms used in medicinal chemistry. IUPAC Pure Appl. Chem. J., 1998, 70(5), 1129-1143.
14. Steinstrasser, I.; Merkle, H.P. Dermal metabolism of topically applied drugs: pathways and models reconsidered. Pharm. Acta. Helv., 1995, 70(1), 3-24.
15. Kao, J.; Patterson, F.K.; Hall, J. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. Toxicol. Appl. Pharmacol., 1985, 81(3 Pt 1), 502-516.
16. Wester, R.C.; Christoffel, J.; Hartway, T.; Poblete, N.; Maibach, H.I.;Forsell, J. Human cadaver skin viability for in vitro percutaneous absorption: storage and detrimental effects of heat-separation and freezing. Pharm. Res., 1998, 15(1), 82-84.
17. Roberts, M.S.; Cross, S.E.; Pellett, M.A. Skin transport. In Dermatological and Transdermal Formulations; Walters, K.A., Ed.; Marcel Dekker: New York, 2002, Vol. 119, pp. 89-195.
18. Higo, N.; Hinz, R.S.; Lau, D.T.; Benet, L.Z.; Guy, R.H. Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement. Pharm. Res., 1992, 9(3), 303-306.
19. Shaikh, N.A.; Ademola, J.I.; Maibach, H.I. Effects of freezing and azide treatment of in vitro human skin on the flux and metabolism of 8-methoxypsoralen. Skin Pharmacol., 1996, 9(4), 274-280.
20. Soucek, P.; Zuber, R.; Anzenbacherova, E.; Anzenbacher, P.; Guengerich, F.P. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol., 2001, 1,11.
21. Baranova, J.; Anzenbacherova, E.; Anzenbacher, P.; Soucek, P. Minipig cytochrome P450 2E1: comparison with human enzyme. Drug Metab. Dispos., 2005, 33(6), 862-865.
22. Prusakiewicz, J.J.; Ackermann, C.; Voorman, R. Comparison of skin esterase activities from different species. Pharm. Res., 2006, 23(7), 1517-1524.
23. Riviere, J.E.; Bowman, K.F.; Monteiro-Riviere, N.A.; Dix, L.P.; Carver, M.P. The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundam. Appl. Toxicol., 1986, 7(3), 444-453.
24. Behrendt, H.; Kampffmeyer, H.G. Absorption and ester cleavage of methyl salicylate by skin of single-pass perfused rabbit ears. Xenobiotica, 1989, 19(2), 131-141.
25. Seki, T.; Hosoya, O.; Yamazaki, T.; Sato, T.; Saso, Y.; Juni, K.; Morimoto, K. A rabbit ear flap perfusion experiment to evaluate the percutaneous absorption of drugs. Int. J. Pharm., 2004, 276(1-2), 29-40.
26. Mahmoud, A.; Haberland, A.; Durrfeld, M.; Heydeck, D.; Wagner, S.; Schafer-Korting, M. Cutaneous estradiol permeation, penetration and metabolism in pig and man. Skin Pharmacol. Physiol., 2005, 18(1), 27-35.
27. Rheinwald, J.G.; Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 1975, 6(3), 331-343.
28. Rheinwald, J.G.; Green, H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell, 1975, 6(3), 317-330.
29. Swanson, H.I. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem. Biol. Interact., 2004, 149(2-3), 69-79.
30. Dame, M.K.; Spahlinger, D.M.; Dasilva, M.; Perone, P.; Dunstan, R.; Varani, J. Establishment and characteristics of Gottingen minipig skin in organ culture and monolayer cell culture: relevance to drug safety testing. In Vitro Cell Dev. Biol. Anim., 2008, 44(7), 245-252.
31. Aldini, G.; Granata, P.; Marinello, C.; Beretta, G.; Carini, M.; Facino, R.M. Effects of UVB radiation on 4-hydroxy-2-transnonenal metabolism and toxicity in human keratinocytes. Chem. Res. Toxicol., 2007, 20(3), 416-423.
32. Boukamp, P.; Petrussevska, R.T.; Breitkreutz, D.; Hornung, J.; Markham, A.; Fusenig, N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol., 1988, 106(3), 761-771.
33. Boderke, P.; Schittkowski, K.; Wolf, M.; Merkle, H.P. Modeling of diffusion and concurrent metabolism in cutaneous tissue. J. Theor. Biol., 2000, 204(3), 393-407.
34. Doebis, C.; Ritter, T.; Brandt, C.; Schonberger, B.; Volk, H.D.; Seifert, M. Efficient in vitro transduction of epithelial cells and keratinocytes with improved adenoviral gene transfer for the application in skin tissue engineering. Transplant. Immunol., 2002, 9(2-4), 323-329.
35. Stinchcomb, A.L. Xenobiotic bioconversion in human epidermis models. Pharm. Res., 2003, 20(8), 1113-1118.
36. Moeller, R.; Lichter, J.; Blomeke, B. Impact of para-phenylenediamine on cyclooxygenases expression and prostaglandin formation in human immortalized keratinocytes (HaCaT). Toxicology, 2008, 249(2-3), 167-175.
37. Slivka, S.R. Testosterone metabolism in an in vitro skin model. Cell Biol. Toxicol., 1992, 8(4), 267-276.
38. Slivka, S.R.; Landeen, L.K.; Zeigler, F.; Zimber, M.P.; Bartel, R.L. Characterization, barrier function, and drug metabolism of an in vitro skin model. J. Invest. Dermatol., 1993, 100(1), 40-46.
39. Poumay, Y.; Dupont, F.; Marcoux, S.; Leclercq-Smekens, M.; Herin, M.; Coquette, A. A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch. Dermatol. Res., 2004, 296(5), 203-211.
40. Nohynek, G.J.; Duche, D.; Garrigues, A.; Meunier, P.A.; Toutain, H.; Leclaire, J. Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol. Lett., 2005, 158(3), 196-212.
41. Gibbs, S.; van de Sandt, J.J.; Merk, H.F.; Lockley, D.J.; Pendlington, R.U.; Pease, C.K. Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr. Drug Metab., 2007, 8(8), 758-772.
42. Bergstrom, M.A.; Ott, H.; Carlsson, A.; Neis, M.; Zwadlo-Klarwasser, G.; Jonsson, C.A.; Merk, H.F.; Karlberg, A.T.; Baron, J.M. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol., 2007, 127(5), 1145-1153.
43. Bronaugh, R.L.; Kraeling, M.E.K.; Yourick, J.J. In Percutaneous Absorption: drugs, cosmetics, mechanisms, methodology, 4th ed.; Bronaugh R.L. and Maibach H.I. Eds.; Taylor & Francis: Boca Raton, 2005, Vol. 155, pp. 45-49.
44. Bronaugh, R.L.; Stewart, R.F. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J. Pharm. Sci., 1985, 74(1), 64-67.
45. Beckley-Kartey, S.A.; Hotchkiss, S.A.; Capel, M. Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse. Toxicol. Appl. Pharmacol., 1997, 145(1), 34-42.
46. Yourick, J.J.; Bronaugh, R.L. Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin. Toxicol. Appl. Pharmacol., 2000, 166(1), 13-23.
47. Armour, A.D.; Powell, H.M.; Boyce, S.T. Fluorescein diacetate for determination of cell viability in tissue-engineered skin. Tissue Eng. Part C Methods, 2008, 14(1), 89-96.
48. Haberland, A.; Schreiber, S.; Maia, C.S.; Rubbelke, M.K.; Schaller, M.; Korting, H.C.; Kleuser, B.; Schimke, I.; Schafer-Korting, M. The impact of skin viability on drug metabolism and permeation -- BSA toxicity on primary keratinocytes. Toxicol. In Vitro, 2006, 20(3), 347-354.
49. van de Sandt, J.J.; Rutten, A.A.; van Ommen, B. Species-specific cutaneous biotransformation of the pesticide propoxur during percutaneous absorption in vitro. Toxicol. Appl. Pharmacol., 1993, 123(1), 144-150.
50. Jugert, F.K.; Agarwal, R.; Kuhn, A.; Bickers, D.R.; Merk, H.F.; Mukhtar, H. Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone. J. Invest. Dermatol., 1994, 102(6), 970-975.
51. Raffali, F.; Rougier, A.; Roguet, R. Measurement and modulation of cytochrome-P450-dependent enzyme activity in cultured human keratinocytes. Skin Pharmacol., 1994, 7(6), 345-354.
52. Enayetallah, A.E.; French, R.A.; Thibodeau, M.S.; Grant, D.F. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J. Histochem. Cytochem., 2004, 52(4), 447-454.
53. Cheung, C.; Smith Pease, C.K. In Comprehensive Handbook of Alcohol-Related Pathology; Preedy, V.R., Watson, R.R. Eds.; Elsevier: London, 2004, Vol. 2, pp. 1501-1514.
54. Zhu, Z.; Hotchkiss, S.A.; Boobis, A.R.; Edwards, R.J. Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. Biochem. Biophys. Res. Commun., 2002, 297(1), 65-70.
55. Richards, M.P.; Poch, S.M. Quantitative analysis of gene expression by reverse transcription polymerase chain reaction and capillary electrophoresis with laser-induced fluorescence detection. Mol. Biotechnol., 2002, 21(1), 19-37.
56. Du, L.; Yermalitsky, V.; Ladd, P.A.; Capdevila, J.H.; Mernaugh, R.; Keeney, D.S. Evidence that cytochrome P450 CYP2B19 is the major source of epoxyeicosatrienoic acids in mouse skin. Arch. Biochem. Biophys., 2005, 435(1), 125-133.
57. Du, L.; Neis, M.M.; Ladd, P.A.; Keeney, D.S. Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J. Pharmacol. Exp. Ther., 2006, 319(3), 1162-1171.
58. Schuster, I.; Egger, H.; Bikle, D.; Herzig, G.; Reddy, G.S.; Stuetz, A.; Stuetz, P.; Vorisek, G. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids, 2001, 66(3-5), 409-422.
59. Schuster, I.; Egger, H.; Reddy, G.S.; Vorisek, G. Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism. Recent Results Cancer Res., 2003, 164, 169-188.
60. Gelardi, A.; Morini, F.; Dusatti, F.; Penco, S.; Ferro, M. Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. Toxicol. In Vitro, 2001, 15(6), 701-711.
61. Smiley, A.K.; Klingenberg, J.M.; Aronow, B.J.; Boyce, S.T.; Kitzmiller, W.J.; Supp, D.M. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J. Invest. Dermatol., 2005, 125(6), 1286-1301.
62. Yengi, L.G.; Xiang, Q.; Pan, J.; Scatina, J.; Kao, J.; Ball, S.E.; Fruncillo, R.; Ferron, G.; Roland Wolf, C. Quantitation of cytochrome P450 mRNA levels in human skin. Anal. Biochem., 2003, 316(1), 103-110.
63. Smith, G.; Ibbotson, S.H.; Comrie, M.M.; Dawe, R.S.; Bryden, A.; Ferguson, J.; Wolf, C.R. Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. Br. J. Dermatol., 2006, 155(2), 275-281.
64. Harris, I.R.; Siefken, W.; Beck-Oldach, K.; Brandt, M.; Wittern, K.P.; Pollet, D. Comparison of activities dependent on glutathione S-transferase and cytochrome P-450 IA1 in cultured keratinocytes and reconstructed epidermal models. Skin Pharmacol. Appl. Skin. Physiol., 2002, 15 (Suppl 1), 59-67.
65. Taimi, M.; Helvig, C.; Wisniewski, J.; Ramshaw, H.; White, J.; Amad, M.; Korczak, B.; Petkovich, M. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J. Biol. Chem., 2004, 279(1), 77-85.
66. Tashiro, K.; Abe, T.; Oue, N.; Yasui, W.; Ryoji, M. Characterization of vitamin D-mediated induction of the CYP 24 transcription. Mol. Cell Endocrinol., 2004, 226(1-2), 27-32.
67. Vyas, P.M.; Roychowdhury, S.; Koukouritaki, S.B.; Hines, R.N.; Krueger, S.K.; Williams, D.E.; Nauseef, W.M.; Svensson, C.K. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases. J. Pharmacol. Exp. Ther., 2006, 319(1), 497-505.
68. Vayalil, P.K.; Mittal, A.; Hara, Y.; Elmets, C.A.; Katiyar, S.K. Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J. Invest. Dermatol., 2004, 122(6), 1480-1487.
69. Ropke, C.D.; da Silva, V.V.; Kera, C.Z.; Miranda, D.V.; de Almeida, R.L.; Sawada, T.C.; Barros, S.B. In vitro and in vivo inhibition of skin matrix metalloproteinases by Pothomorphe umbellata root extract. Photochem. Photobiol., 2006, 82(2), 439-442.
70. Pavek, P.; Dvorak, Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab., 2008, 9(2), 129-143.
71. Schnetz, E.; Fartasch, M. Microdialysis for the evaluation of penetration through the human skin barrier - a promising tool for future research? Eur. J. Pharm. Sci., 2001, 12(3), 165-174.
72. Herkenne, C.; Alberti, I.; Naik, A.; Kalia, Y.N.; Mathy, F.X.; Preat, V.; Guy, R.H. In vivo methods for the assessment of topical drug bioavailability. Pharm. Res., 2008, 25(1), 87-103.
73. el Marbouh, L.; Arellano, C.; Philibert, C.; Evrard, P.; Poey, J.; Houin, G. In vivo study of percutaneous absorption of 4-chloroaniline using microdialysis in the rat. Arzneimittelforschung, 2000, 50(11), 1033-1036.
74. Mathy, F.X.; Denet, A.R.; Vroman, B.; Clarys, P.; Barel, A.; Verbeeck, R.K.; Preat, V. In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat. Skin Pharmacol. Appl. Skin Physiol., 2003, 16(1), 18-27.
75. Surber, C.; Smith, F.P.S.E.W.; Maibach, H.I. In Percutaneous Absorption: drugs, cosmetics, mechanisms, methodology, 4th ed.; Bronaugh, R.L.; Maibach, H.I., Eds.; Taylor & Francis: Boca Raton, 2005, Vol. 155, pp. 361-381.
76. Li, Q.; Tsuji, H.; Kato, Y.; Sai, Y.; Kubo, Y.; Tsuji, A. Characterization of the transdermal transport of flurbiprofen and indomethacin. J. Control. Release, 2006, 110(3), 542-556.
77. Boury-Jamot, M.; Sougrat, R.; Tailhardat, M.; Le Varlet, B.; Bonte, F.; Dumas, M.; Verbavatz, J.M. Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter? Biochim. Biophys. Acta., 2006, 1758(8), 1034-1042.
78. Lan, L.B.; Dalton, J.T.; Schuetz, E.G. Mdr1 limits CYP3A metabolism in vivo. Mol. Pharmacol., 2000, 58(4), 863-869.
79. Baron, J.M.; Goh, L.B.; Yao, D.; Wolf, C.R.; Friedberg, T. Modulation of P450 CYP3A4-dependent metabolism by P-glycoprotein: implications for P450 phenotyping. J. Pharmacol. Exp. Ther., 2001, 296(2), 351-358.
80. Baron, J.M.; Holler, D.; Schiffer, R.; Frankenberg, S.; Neis, M.; Merk, H.F.; Jugert, F.K. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol., 2001, 116(4), 541-548.
81. Schiffer, R.; Neis, M.; Holler, D.; Rodriguez, F.; Geier, A.; Gartung, C.; Lammert, F.; Dreuw, A.; Zwadlo-Klarwasser, G.; Merk, H.; Jugert, F.; Baron, J.M. Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. J. Invest. Dermatol., 2003, 120(2), 285-291.
82. Schmuth, M.; Ortegon, A.M.; Mao-Qiang, M.; Elias, P.M.; Feingold, K.R.; Stahl, A. Differential expression of fatty acid transport proteins in epidermis and skin appendages. J. Invest. Dermatol., 2005, 125(6), 1174-1181.
83. Ito, K.; Kato, Y.; Tsuji, H.; Nguyen, H.T.; Kubo, Y.; Tsuji, A. Involvement of organic anion transport system in transdermal absorption of flurbiprofen. J. Control. Release, 2007, 124(1-2), 60-68.
84. Masters, B.R.; So, P.T.; Gratton, E. Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. Biophys. J., 1997, 72(6), 2405-2412.
85. Masters, B.R.; So, P.T.; Gratton, E. Multiphoton excitation microscopy of in vivo human skin. Functional and morphological optical biopsy based on three-dimensional imaging, lifetime measurements and fluorescence spectroscopy. Ann. N. Y. Acad. Sci., 1998, 838, 58-67.
86. Konishi, Y.; Kobayashi, S.; Shimizu, M. Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. J. Agric. Food Chem., 2003, 51(25), 7296-7302.
87. van Zanden, J.J.; Wortelboer, H.M.; Bijlsma, S.; Punt, A.; Usta, M.; Bladeren, P.J.; Rietjens, I.M.; Cnubben, N.H. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem. Pharmacol., 2005, 69(4), 699-708.
88. Baririan, N.; Desager, J.P.; Petit, M.; Horsmans, Y. CYP3A4 activity in four different animal species liver microsomes using 7-benzyloxyquinoline and HPLC/spectrofluorometric determination. J. Pharm. Biomed. Anal., 2006, 40(1), 211-214.
89. Chapman, P.H.; Rawlins, M.D.; Shuster, S. Activity of aryl hydrocarbon hydroxylase in psoriatic skin. Lancet, 1979, 1(8111), 297-298.
90. Martin, R.J.; Denyer, S.P.; Hadgraft, J. Skin metabolism of topically applied compounds. Int. J. Pharm., 1987, 39, 23-32.
91. Finnen, M.J.; Shuster, S.; Lawrence, C.M.; Rawlins, M.D. Aryl hydrocarbon hydroxylase activity and psoriasis. Biochem. Pharmacol., 1983, 32(11), 1707-1711.
92. Bickers, D.R.; Mukhtar, H.; Dutta-Choudhury, T.; Marcelo, C.L.; Voorhees, J.J. Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. J. Invest. Dermatol., 1984, 83(1), 51-56.
93. Smith, G.; Dawe, R.S.; Clark, C.; Evans, A.T.; Comrie, M.M.; Wolf, C.R.; Ferguson, J.; Ibbotson, S.H. Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation. J. Invest. Dermatol., 2003, 121(2), 390-398.
94. Smith, G.; Wolf, C.R.; Deeni, Y.Y.; Dawe, R.S.; Evans, A.T.; Comrie, M.M.; Ferguson, J.; Ibbotson, S.H. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet, 2003, 361(9366), 1336-1343.
95. Paraskevaidis, A.; Drakoulis, N.; Roots, I.; Orfanos, C.E.; Zouboulis, C.C. Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology, 1998, 196(1), 171-175.
96. Rowe, J.M.; Welsh, C.; Pena, R.N.; Wolf, C.R.; Brown, K.; Whitelaw, C.B. Illuminating role of CYP1A1 in skin function. J. Invest. Dermatol., 2008, 128(7), 1866-1868.
97. Bach, M.; Lippold, B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm., 1998, 46(1), 1-13.
98. Liu, P.; Higuchi, W.I.; Song, W.Q.; Kurihara-Bergstrom, T.; Good, W.R. Quantitative evaluation of ethanol effects on diffusion and metabolism of beta-estradiol in hairless mouse skin. Pharm. Res., 1991, 8(7), 865-872.
99. Hayashi, T.; Iida, Y.; Hatanaka, T.; Kawaguchi, T.; Sugibayashi, K.; Morimoto, Y. The effects of several penetration-enhancers on the simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin. Int. J. Pharm., 1997, 154, 141-148.
100. Vavrova, K.; Hrabalek, A.; Dolezal, P.; Holas, T.; Klimentova, J. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers. J. Control. Release, 2005, 104(1), 41-49.
101. Hrabalek, A.; Dolezal, P.; Vavrova, K.; Zbytovska, J.; Holas, T.; Klimentova, J.; Novotny, J. Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin. Pharm. Res., 2006, 23(5), 912-919.
102. Zhao, L.; Fang, L.; Xu, Y.; Zhao, Y.; He, Z. Effect of Oacylmenthol on transdermal delivery of drugs with different lipophilicity. Int. J. Pharm., 2008, 352(1-2), 92-103.
103. Lombardi Borgia, S.; Schlupp, P.; Mehnert, W.; Schafer-Korting, M. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use. Eur. J. Pharm. Biopharm., 2008, 68(2), 380-389.
104. Brown, M.B.; Traynor, M.J.; Martin, G.P. and Akomeah, F.K. Transdermal drug delivery systems: skin perturbation devices. Methods Mol. Biol., 2008, 437, 119-139.
105. Hikima, T.; Tojo, K.; Maibach, H.I. Skin metabolism in transdermal therapeutic systems. Skin Pharmacol. Physiol., 2005, 18(4), 153-159.
106. Hikima, T.; Tojo, K. Binding of prednisolone and its ester prodrugs in the skin. Pharm. Res., 1997, 14(2), 197-202.
107. Cross, S.E.; Anderson, C.; Roberts, M.S. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br. J. Clin. Pharmacol., 1998, 46(1), 29-35.
108. Thompson, M.S.; Gustafsson, L.; Palsson, S.; Bendsoe, N.; Stenberg, M.; Klinteberg, C.; Andersson-Engels, S.; Svanberg, K. Photodynamic therapy and diagnostic measurements of basal cell carcinomas using esterified and non-esterified deltaaminolevulinic acid. J. Porphyr. Phthalocya., 2001, 5(2), 147-153.
109. Valiveti, S.; Paudel, K.S.; Hammell, D.C.; Hamad, M.O.; Chen, J.; Crooks, P.A.; Stinchcomb, A.L. In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs. Pharm. Res., 2005, 22(6), 981-989.
110. De Rosa, F.S.; Tedesco, A.C.; Lopez, R.F.; Pierre, M.B.; Lange, N.; Marchetti, J.M.; Rotta, J.C.; Bentley, M.V. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J. Control. Release, 2003, 89(2), 261-269.
111. Beall, H.D.; Sloan, K.B. Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs. Int. J. Pharm., 2001, 217(1-2), 127-137.
112. Sloan, K.B.; Wasdo, S.C.; Rautio, J. Design for optimized topical delivery: Prodrugs and a paradigm change. Pharm. Res., 2006, 23(12), 2729-2747.
113. Wang, J.J.; Sung, K.C.; Huang, J.F.; Yeh, C.H.; Fang, J.Y. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study. J. Pharm. Pharmacol., 2007, 59(7), 917-925.